Mutation-selection balance and compensatory mechanisms in tumour evolution.

Area of Science:

• Oncology
• Genetics
• Cancer Biology

Background:

• Intratumour heterogeneity and phenotypic plasticity enable cancer treatment resistance and survival.
• Somatic aberrations, epigenetic, and metabolic adaptations are key drivers of cancer progression.
• A comprehensive understanding of the interplay between various genomic aberrations in cancer is lacking.

Purpose of the Study:

• To elucidate the temporal order of genomic aberrations during tumor initiation and progression.
• To investigate the balance between mutation levels and selective pressures in shaping aberration patterns.
• To highlight the importance of understanding genetic aberrations in conjunction with microenvironment, epigenetic, and metabolic states for cancer management.

Main Methods:

• The study proposes a model for the temporal sequence of genomic aberrations.
• Analysis of the interplay between mutation levels and selective pressures.
• Integration of genetic aberrations with epigenetic and metabolic cellular states.

Main Results:

• Genomic aberrations generally follow a temporal order, starting with repeat instability, followed by larger aberrations.
• Compensatory effects maintain robust tumor fitness throughout progression.
• This ordered progression contributes to treatment resistance and survival under stress.

Conclusions:

• Understanding the temporal order of genomic aberrations is crucial for cancer research.
• Integrating genetic, epigenetic, metabolic, and microenvironmental factors is essential for effective cancer detection and treatment.
• This knowledge can pave the way for novel therapeutic strategies and improved early detection of cancer.